Latest Strategic Portfolio News

News Corporation has announced a significant secondary offering of over 14 million Class B shares by key family trusts, signaling a notable insider sell-down without direct proceeds to the company.

Desane Group Holdings has sold its commercial property at 13 Sirius Road, Lane Cove for $8.7 million, marking a strategic shift to fund future growth opportunities.

Lion Energy has agreed to sell its minority interest in the Seram Non-Bula PSC for US$1.2 million, refocusing its efforts on the higher-potential East Seram PSC exploration program.

Mammoth Minerals has agreed to sell a 90% stake in its Paterson copper-gold project to Cloudbreak Discovery for AUD 3.1 million in shares, refocusing its efforts on high-grade US assets while retaining a strategic interest in Paterson.

Magnum Mining & Exploration Limited is intensifying its US asset review, spotlighting promising rare earth elements and critical minerals prospects at its Parker Gold and Buena Vista Iron projects amid shifting geopolitical priorities.

Collins Foods delivered record $1.5 billion revenue in FY25, pivoting to focus on KFC growth in Australia and Germany while exiting Taco Bell. Despite impairments and wage remediation costs, the company targets strong profit growth in FY26.

Infinity Mining Limited’s 2025 AGM highlighted significant portfolio reshaping, including asset sales and acquisitions, alongside promising exploration results at the Cangai Copper Project.

PEXA Group Limited reported a 16% revenue increase to $393.6 million for FY25, driven by growth across its Australian Exchange, UK International business, and Digital Solutions segments. Despite a statutory net loss of $76.1 million due to impairments and deferred tax derecognition, core EBITDA rose 21% with improved margins.

BNK Banking Corporation Limited has reported a significant turnaround in its FY25 financial results, driven by margin expansion and a robust capital position. The bank’s strategic portfolio reshaping and disciplined cost management underpin its improved profitability and outlook.

CI1 reported a sharp 57% revenue decline in FY25 but reduced its comprehensive loss by 64% through strategic disposals and capital returns. The company’s financial services operations in Australia and Singapore faced tough market conditions, prompting a portfolio reshaping.

Clarity Pharmaceuticals reported a $64.3 million loss for FY2025 alongside significant clinical progress and a $203.6 million placement to fund its radiopharmaceutical pipeline expansion.

South32 reported a robust turnaround in FY25 with a profit after tax of US$213 million and underlying earnings of US$666 million, driven by operational gains and strategic portfolio shifts. The company also advanced construction at its Hermosa project and maintained a strong balance sheet with net cash of US$123 million.